tradingkey.logo

Envista Holdings Corp

NVST
查看詳細走勢圖
21.945USD
-0.055-0.25%
交易中 美東報價延遲15分鐘
3.62B總市值
233.26本益比TTM

Envista Holdings Corp

21.945
-0.055-0.25%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.25%

5天

-1.37%

1月

+4.25%

6月

+13.41%

今年開始到現在

+13.76%

1年

+15.80%

查看詳細走勢圖

TradingKey Envista Holdings Corp股票評分

單位: USD 更新時間: 2025-12-24

操作建議

Envista Holdings Corp當前公司基本面數據相對健康,增長潛力較大。當前估值合理,在醫療設備與耗材行業排名43/206位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價22.33。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Envista Holdings Corp評分

相關信息

行業排名
43 / 206
全市場排名
117 / 4562
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 15 分析師
持有
評級
22.333
目標均價
+11.61%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Envista Holdings Corp亮點

亮點風險
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
估值高估
公司最新PE估值233.84,處於3年歷史高位
機構減倉
最新機構持股196.49M股,環比減少13.81%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉35.72K股

Envista Holdings Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Envista Holdings Corp簡介

Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
公司代碼NVST
公司Envista Holdings Corp
CEOKeel (Paul A)
網址https://envistaco.com/en

常見問題

Envista Holdings Corp(NVST)的當前股價是多少?

Envista Holdings Corp(NVST)的當前股價是 21.945。

Envista Holdings Corp 的股票代碼是什麼?

Envista Holdings Corp的股票代碼是NVST。

Envista Holdings Corp股票的52週最高點是多少?

Envista Holdings Corp股票的52週最高點是22.680。

Envista Holdings Corp股票的52週最低點是多少?

Envista Holdings Corp股票的52週最低點是14.220。

Envista Holdings Corp的市值是多少?

Envista Holdings Corp的市值是3.62B。

Envista Holdings Corp的淨利潤是多少?

Envista Holdings Corp的淨利潤為-1.12B。

現在Envista Holdings Corp(NVST)的股票是買入、持有還是賣出?

根據分析師評級,Envista Holdings Corp(NVST)的總體評級為持有,目標價格為22.333。

Envista Holdings Corp(NVST)股票的每股收益(EPS TTM)是多少

Envista Holdings Corp(NVST)股票的每股收益(EPS TTM)是0.094。
KeyAI